| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,250 | 1,305 | 13:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 192 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen | |
| 06.11.25 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2025 | 174 | GlobeNewswire (Europe) | SIGNIFICANT PROGRESS IN PERFORMANCE AS MARKET ACTIVITY INCREASES
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2025 (Jul - Sep)• The strategic organizational change announced in June, aimed at aligning... ► Artikel lesen | |
| 21.08.25 | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 175 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 01.08.25 | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 177 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 31.07.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 353 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 24.07.25 | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 231 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 195 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen | |
| 11.07.25 | Mentice AB: Mentice AB Announces Consolidation of Physical Simulation Operations to Strengthen Long-Term Efficiency and Global Service Delivery | 349 | GlobeNewswire (Europe) | Gothenburg, Sweden, July 11, 2025 - Mentice AB (publ), a global leader in simulation solutions for image-guided therapies, today announces the decision to consolidate its research and development (R&D)... ► Artikel lesen | |
| 16.06.25 | Mentice AB: Mentice AB announces the intent for a strategic workforce realignment to enhance focus and operational efficiency and the intent for a rights issue of max 10% of the share capital | 240 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announces the intent of a strategic workforce realignment and the intent of planning... ► Artikel lesen | |
| 08.05.25 | Mentice AB: Mentice publishes the company's interim report for the period January-March 2025 | 175 | GlobeNewswire (Europe) | STABLE GROWTH AND STRATEGIC CHANGES IN THE FIRST QUARTER
SIGNIFICANT EVENTS DURING THE FIRST QUARTER 2025 (JAN - MAR)Mentice announced a significant order from a top 20 global Med Tech company for 6.5... ► Artikel lesen | |
| 17.04.25 | Mentice AB: Mentice AB Publishes Annual and Sustainability Report for 2024 - Strong finish to 2024 following a transitional year | 258 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg - a globally recognized leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report for 2024.
The... ► Artikel lesen | |
| 13.02.25 | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2024 | 199 | GlobeNewswire (Europe) | STRONG CLOSING QUARTER
SIGNIFICANT EVENTS DURING THE FORTH QUARTER 2024 (OCT - DEC)Mentice announced the recruitment of Frans Venker as new CEO, starting Jan 1, 2025.The order intake during the quarter... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| PENUMBRA | 286,40 | -0,69 % | Aktien New York: Gut erholt - Optimismus von TSMC treibt Chip-Branche an | NEW YORK (dpa-AFX) - Optimistische Wachstumsprognosen des taiwanesischen Chip-Giganten TSMC haben den US-Aktienmärkten und vor allem dem Halbleitersektor zu einer soliden Erholung verholfen. TSMC will... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | Märkte am Morgen: Gold, Silber, Bitcoin, Amgen, Alphabet, AMD, SAP, Siemens Healthineers, BASF | Das Umfeld an den Aktienmärkten ist aktuell alles andere als einfach. Das hat sich gestern mal wieder deutlich gezeigt. Der DAX geriet nach guten Start unter Druck und schloss 0,72 Prozent tiefer bei... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| FRESENIUS | 49,760 | +1,06 % | Fresenius: 2026 setzt sich das Wachstum fort | Am 25. Februar wird Fresenius Zahlen zum vierten Quartal publizieren. Die Analysten der DZ Bank rechnen mit einer soliden Entwicklung. Wachstumsinvestitionen bei Kabi dürften sich bei den Margen bemerkbar... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen |